Recalls / Class II
Class IID-0482-2025
Product
Tirzepatide Injections, 10mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112
- Affected lot / code info
- Lot, expiry: H272962, exp 12/5/2025; S5045185, exp 5/20/2025; H272962, exp 12/5/2025; H270625, exp 9/30/2025
Why it was recalled
Lack of Assurance of Sterility
Recalling firm
- Firm
- Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)
- Notification channel
- Type
- Voluntary: Firm initiated
- Address
- 88 Inverness Cir E Unit A204, Englewood, Colorado 80112-5521
Distribution
- Quantity
- 24 syringes
- Distribution pattern
- USA Nationwide
Timeline
- Recall initiated
- 2025-05-21
- FDA classified
- 2025-06-20
- Posted by FDA
- 2025-07-02
- Status
- Ongoing
Source: openFDA Drug Enforcement endpoint. Recall record D-0482-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.